Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Current Assets (2017 - 2025)

Historic Current Assets for Silo Pharma (SILO) over the last 10 years, with Q3 2025 value amounting to $6.2 million.

  • Silo Pharma's Current Assets fell 2538.7% to $6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.2 million, marking a year-over-year decrease of 2538.7%. This contributed to the annual value of $7.1 million for FY2024, which is 741.66% down from last year.
  • As of Q3 2025, Silo Pharma's Current Assets stood at $6.2 million, which was down 2538.7% from $6.4 million recorded in Q2 2025.
  • Silo Pharma's 5-year Current Assets high stood at $12.9 million for Q3 2022, and its period low was $5.0 million during Q2 2021.
  • Over the past 5 years, Silo Pharma's median Current Assets value was $8.3 million (recorded in 2024), while the average stood at $8.5 million.
  • Its Current Assets has fluctuated over the past 5 years, first skyrocketed by 125749.91% in 2021, then crashed by 3721.48% in 2024.
  • Silo Pharma's Current Assets (Quarter) stood at $10.4 million in 2021, then rose by 11.24% to $11.6 million in 2022, then tumbled by 33.62% to $7.7 million in 2023, then fell by 7.42% to $7.1 million in 2024, then dropped by 13.32% to $6.2 million in 2025.
  • Its Current Assets stands at $6.2 million for Q3 2025, versus $6.4 million for Q2 2025 and $5.6 million for Q1 2025.